Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 10-2002 | 07-2002 | 04-2002 | 01-2002 | 10-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 1,422 | 1,904 | -3,521 | N/A |
| Depreciation Amortization | N/A | 2,528 | 1,608 | 741 | N/A |
| Accounts receivable | N/A | -7,379 | -2,589 | -2,473 | N/A |
| Accounts payable and accrued liabilities | N/A | -1,551 | -2,769 | 1,432 | N/A |
| Other Working Capital | N/A | -3,122 | 1,645 | 11,660 | N/A |
| Other Operating Activity | 0 | 11,381 | 5,559 | 1,142 | 0 |
| Operating Cash Flow | $N/A | $3,279 | $5,358 | $8,981 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -1,954 | -1,585 | -1,285 | N/A |
| Other Investing Activity | 0 | -206 | -1,082 | 110 | 0 |
| Investing Cash Flow | $N/A | $-2,160 | $-2,667 | $-1,175 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 15,989 | 13,289 | 5,235 | N/A |
| Debt Issued | N/A | 60 | 0 | 34 | N/A |
| Debt Repayment | N/A | -3,786 | -2,868 | -1,883 | N/A |
| Common Stock Issued | N/A | 7,610 | 7,459 | 180 | N/A |
| Other Financing Activity | 0 | -28,468 | -20,667 | -12,466 | 0 |
| Financing Cash Flow | $N/A | $-8,595 | $-2,787 | $-8,900 | $N/A |
| Beginning Cash Position | N/A | 8,695 | 8,695 | 8,695 | N/A |
| End Cash Position | N/A | 1,219 | 8,599 | 7,601 | N/A |
| Net Cash Flow | $N/A | $-7,476 | $-96 | $-1,094 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 3,279 | 5,358 | 8,981 | N/A |
| Capital Expenditure | N/A | -1,954 | -1,585 | -1,285 | N/A |
| Free Cash Flow | 0 | 1,325 | 3,773 | 7,696 | 0 |